Breaking News

Piramal’s Mumbai Facility Gains Indian GLP Certification

Areas of toxicity, mutagenicity, analytical and clinical chemistry testing in compliance

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Piramal Enterprises Ltd.’s R&D facility in Goregaon, Mumbai, has received GLP Compliance Certification from the National GLP Compliance Monitoring Authority (NGCMA), Government of India. The certification covered areas of toxicity, mutagenicity, analytical and clinical chemistry testing, as well as hERG, bioanalysis and toxicokinetic evaluation.   The Goregaon facility provides drug discovery and development of New Chemical Entities (NCE) in the area of oncology and metabolic disorders.   Dr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters